반응 #1452973

ord-2fff77945a5c4b8fa5dd9c7ccb6d8ce4

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타The product was purified by reverse phase HPLC

실험 절차

1-[4-(5-Chloro-7-morpholin-4-yl-thiazolo[5,4-d]pyrimidin-2-ylmethyl)-piperazin-1-yl]-2-hydroxy-propan-1-one (100 mg) was reacted with 72 mg of 3-(4,4,5,5-tetramethyl-1,3,2,-dioxaborolan-2-yl)quinoline via General Procedure A. The product was purified by reverse phase HPLC to yield 43.5 mg of 106. MS (Q1) 520.3 (M)+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07893059B2uspto-grants-2011_02